The current valuation score of Krystal Biotech Inc is 7.39, ranking 229 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is 45.42, which is 880.89% below the recent high of 445.49 and 342.84% above the recent low of -110.29.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.